We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.
- Authors
Crona, Daniel J.; Faso, Aimee; Nishijima, Tomohiro F.; McGraw, Kathleen A.; Galsky, Matthew D.; Milowsky, Matthew I.
- Abstract
Introduction. Cisplatin, a platinum-based antineoplastic agent, is the cornerstone for the treatment of many malignancies. Nephrotoxicity is the primary dose-limiting toxicity, and various hydration regimens and supplementation strategies are used to prevent cisplatin-induced kidney injury. However, evidence-based recommendations on specific hydration regimens are limited. A systematic review was performed to evaluate clinical studies that have examined hydration and supplementation strategies to prevent cisplatin-induced nephrotoxicity. Materials and Methods. PubMed and Excerpta Medica databases were searched from 1966 through October 2015 for clinical trials and other studies focused on hydration regimens to prevent nephrotoxicity in cancer patients treated with cisplatin. The University of Oxford Centre for Evidence-Based Medicine criteria were used to grade level of evidence. Results. Among the 1,407 identified studies, 24 were included in this systematic review. All studies differed on type, volume, and duration of hydration. Among the 24 studies, 5 evaluated short-duration hydration, 4 evaluated low-volume hydration, 4 investigated magnesium supplementation, and 7 reviewed forced diuresis with hydration. Short-duration and lower-volume hydration regimens are effective in preventing cisplatin-induced nephrotoxicity. Magnesium supplementation may have a role as a nephroprotectant, and forced diuresis may be appropriate in some patients receiving cisplatin. Conclusion. Hydration is essential for all patients to prevent cisplatin-induced nephrotoxicity. Specifically, short-duration, low-volume, outpatient hydration with magnesium supplementation and mannitol forced diuresis (in select patients) represent best practice principles for the safe use of cisplatin.
- Subjects
NEPHROTOXICOLOGY; CANCER patients; CISPLATIN; CLINICAL trials; DATABASES; DIURESIS; FLUID therapy; MEDICAL information storage &; retrieval systems; KIDNEYS; MAGNESIUM; MEDLINE; ONCOLOGY; ONLINE information services; SYSTEMATIC reviews; EVIDENCE-based medicine; MANNITOL; TREATMENT duration; PREVENTION
- Publication
Oncologist, 2017, Vol 22, Issue 5, p609
- ISSN
1083-7159
- Publication type
Article
- DOI
10.1634/theoncologist.2016-0319